The association and prediction value of acylcarnitine on diabetic nephropathy in Chinese patients with type 2 diabetes mellitus

[1] Khan MAB(2020)Epidemiology of type 2 diabetes - global burden of Disease and Forecasted Trends J Epidemiol Glob Health 10 107-11

[2] Hashim MJ(2019)Global trends in diabetes complications: a review of current evidence Diabetologia 62 3-16

[3] King JK(2018)Update of pathophysiology and management of diabetic kidney disease J Formos Med Assoc 117 662-75

[4] Govender RD(2014)Markers of and risk factors for the development and progression of diabetic kidney disease Am J Kidney Dis 63 39-62

[5] Mustafa H(2015)Acylcarnitines–old actors auditioning for new roles in metabolic physiology Nat Rev Endocrinol 11 617-25

[6] Al Kaabi J(2017)Walch A. N-acyl Taurines and Acylcarnitines cause an imbalance in insulin synthesis and secretion provoking beta cell dysfunction in type 2 diabetes Cell Metab 25 1334-47

[7] Harding JL(2020)Contributions of amino acid, acylcarnitine and sphingolipid profiles to type 2 diabetes risk among south-asian surinamese and dutch adults BMJ Open Diabetes Res Care 8 e001003-8

[8] Pavkov ME(2020)Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic asian population BMJ Open Diabetes Res Care 8 e001315-34

[9] Magliano DJ(2019)Plasma tyrosine and its interaction with low high-density lipoprotein cholesterol and the risk of type 2 diabetes mellitus in chinese J Diabetes Investig 10 491-98

[10] Shaw JE(2019)Standards of Medical Care in Diabetes-2019 abridged for primary care providers Clin Diabetes 37 11-63

[1] Khan MAB(2020)Epidemiology of type 2 diabetes - global burden of Disease and Forecasted Trends J Epidemiol Glob Health 10 107-11

[2] Hashim MJ(2019)Global trends in diabetes complications: a review of current evidence Diabetologia 62 3-16

[3] King JK(2018)Update of pathophysiology and management of diabetic kidney disease J Formos Med Assoc 117 662-75

[4] Govender RD(2014)Markers of and risk factors for the development and progression of diabetic kidney disease Am J Kidney Dis 63 39-62

[5] Mustafa H(2015)Acylcarnitines–old actors auditioning for new roles in metabolic physiology Nat Rev Endocrinol 11 617-25

[6] Al Kaabi J(2017)Walch A. N-acyl Taurines and Acylcarnitines cause an imbalance in insulin synthesis and secretion provoking beta cell dysfunction in type 2 diabetes Cell Metab 25 1334-47

[7] Harding JL(2020)Contributions of amino acid, acylcarnitine and sphingolipid profiles to type 2 diabetes risk among south-asian surinamese and dutch adults BMJ Open Diabetes Res Care 8 e001003-8

[8] Pavkov ME(2020)Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic asian population BMJ Open Diabetes Res Care 8 e001315-34

[9] Magliano DJ(2019)Plasma tyrosine and its interaction with low high-density lipoprotein cholesterol and the risk of type 2 diabetes mellitus in chinese J Diabetes Investig 10 491-98

[10] Shaw JE(2019)Standards of Medical Care in Diabetes-2019 abridged for primary care providers Clin Diabetes 37 11-63